Eight days in, Ashya King’s therapy proceeds ‘according to plan’

Eight days in, Ashya King’s therapy proceeds ‘according to plan’

Proton center’s spokeswoman says it is still too early to make a prognosis; 23 radiations remain

Prague, Sept. 23 (ČTK) — The proton therapy of five-year-old Ashya King, a Briton who suffers from brain tumor, is proceeding according to plan, but it is too early to make any prognosis, Prague Proton Centre spokeswoman Iva Taťounová told the Czech News Agency today.

Pavlína Danková, spokeswoman for the Prague–Motol Teaching Hospital from where the boy is transported to the Proton Centre on a daily basis, confirmed that no complications have occurre

The boy underwent the first treatment session Sept. 15. Today he had his seventh session. In total, 30 radiation sessions have been planned for him. The proton therapy lasts six weeks.

The previous seven radiations and the next six ones focus on the whole brain to ensure that the tumor does not spread further to the body. The remaining 17 radiations will be targeted at the brain tumor.

Taťounová said the boy’s motor activity has been improving, and he has been rehabilitating. This improvement occurred as more time has passed from an operation Ashya King had undergone when he was still in Britain, she said.

_78502818_000withmotherinaenesthesiaroom

The proton treatment saves the healthy tissues around the tumor.

The parents took Ashya to Spain from a British hospital without doctors’ knowledge in late August. They reportedly wanted to sell a recreation facility they had in Spain to get money for the treatment. British authorities issued an arrest warrant on them citing neglect of care. Before they withdrew it, the Kings spent several days in custody.

The family came to Prague Sept. 8. The parents need 1.8 million Kč to pay for the treatment.

 

Our Facebook page Comments

Medlines

We are proud to announce that MEDLINES – Healthcare headlines started its’ very own blog site. Our mission is to bring the very best of the news and newsworthy issues of the medical field, from university news to business and tech info.

Close